My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

2.050 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

A Reply To Dr Biks on $SAVA PTau-181 ↗

September 11, 2021

Data by BruinAnteater @BruinStocks - Twitter, @BruinAnteaterStock - Stocktwits A Quick Introduction Hello, allow me to introduce myself. On twitter I am known as @BruinStocks, and...

Via Benzinga

What Happens When A Biotech Stock Blows Up: How Our Hedged Portfolio Method Limited The Damage With Cassava Sciences ↗

September 11, 2021

Screen capture via Cassava Sciences' video for their Simulfilam Alzheimer's disease treatment. When A Biotech Stock Goes The Wrong Way In our last post (Corona Doom...

Via Benzinga

When A Biotech Stock Blows Up ↗

September 11, 2021

How to limit the damage when something goes wrong. We can't always be right, which is why we hedge..

Via Talk Markets

Cassava Sciences Stock Still Poses Risks After Absorbing Data Controversy ↗

September 09, 2021

Simufilam's eventual approval is still uncertain. Its fading popularity among the Reddit set is a concern as well. Even after it 57%+ price haircut, approach SAVA stock cautiously.

Via InvestorPlace

Topics Fraud

Better Buy: Biogen vs. Cassava Sciences ↗

September 04, 2021

These two biotechs are going after a significant market: Alzheimer's.

Via The Motley Fool

Cassava Plummets — Again — After CEO Denies Data Manipulation Claims ↗

September 03, 2021

Cassava CEO Remi Barbier denied allegations of data manipulation in the firm's Alzheimer's research on Friday. But SAVA stock tumbled, again.

Via Investor's Business Daily

Cassava CEO Goes Offensive Over Data Allegations ↗

September 03, 2021

Cassava Sciences Inc (NASDAQ: SAVA) has garnered attention recently after a citizen petition with the FDA suggested that the use of Alzheimer's candidate data is based...

Via Benzinga

Fraud Allegations Are Unlikely to Keep Cassava Stock Down ↗

September 03, 2021

Cassava's unchallenged safety and cognition data will result in the FDA allowing it to conduct a Phase 3 trial. SAVA stock is a buy.

Via InvestorPlace

Topics Fraud

Cassava Sciences Stock Will Fall Further on Data Manipulation Allegations ↗

September 02, 2021

SAVA stock is still one of the best performers this year, but the recent allegations mean shares will fall further as the story develops.

Via InvestorPlace

Here's How You Handle a Volatile Stock Like Cassava Sciences ↗

September 02, 2021

Investing in biotech stocks can pay off big, but only if their research pans out. Pay attention to the risk-reward ratio -- and control your greed.

Via The Motley Fool

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself ↗

September 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 01, 2021

Gainers Neuronetics (NASDAQ:STIM) stock rose 16.51% to $7.83 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 675.7K shares...

Via Benzinga

Wait to See How the Cassava Sciences Allegations Pan Out ↗

August 31, 2021

Allegations have been leveled against Cassava Sciences. SAVA stock has fallen by more than 50% as a result. Is this a buy-on-the-dip moment?

Via InvestorPlace

Insiders Like Cassava Sciences, Which Might Be Good News ↗

August 30, 2021

Insider transactions have historically proven quite prescient for the trajectory of SAVA stock, so what do they imply today?

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 30, 2021

Gainers Valneva (NASDAQ:VALN) stock moved upwards by 29.61% to $49.9 during Monday's regular session. Valneva's stock is trading at a volume of 143.0K shares as of...

Via Benzinga

Why This Cassava Sciences Analyst Is Dropping Coverage ↗

August 30, 2021

The selling in Cassava Sciences, Inc. (NASDAQ:SAVA) stock ...

Via Benzinga

3 Reasons Cassava Sciences Stock Isn't Worth the Risk ↗

August 30, 2021

There is a lot of smoke. Is there fire?

Via The Motley Fool

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 30, 2021

Gainers Valneva (NASDAQ:VALN) stock rose 17.45% to $45.22 during Monday's pre-market session. The market value of their outstanding shares is at $2.2 billion....

Via Benzinga

Cassava Sciences Is on the Ropes, so Watch for a Dip-Buy Opportunity ↗

August 30, 2021

Amid a regulatory tug-of-war over a proposed Alzheimer's disease treatment, SAVA stock has become a speculator's playground.

Via InvestorPlace

60 Biggest Movers From Friday ↗

August 30, 2021

Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 80.9% to close at $5.30 on Friday. The company recently reported a Q2 loss of $5.13 per share. Navios Maritime Acquisition...

Via Benzinga

The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In A Light Week ↗

August 29, 2021

Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. and BioNTech SE. The stocks subsequently moved back and...

Via Talk Markets

The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week ↗

August 29, 2021

Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. (NYSE: PFE) and BioNTech SE (...

Via Benzinga

Mid-Afternoon Market Update: Crude Oil Rises 2%; Navios Maritime Acquisition Shares Climb On Merger News ↗

August 27, 2021

Toward the end of trading Friday, the Dow traded up 0.63% to 35,436.38 while the NASDAQ rose 1.23% to 15,130.14. The S&P also rose, gaining 0.88% to 4,509.16. The U.S. has the...

Via Benzinga

Topics Stocks

Major Benchmarks Gain Amid Economic Stimulus Commentary ↗

August 27, 2021

Investors are unpacking comments by Federal Reserve Chairman Jerome Powell.

Via Talk Markets

Topics Economy

Most Active Equity Options For Midday - Friday, Aug. 27 ↗

August 27, 2021

Top Tickers: AAPL, TSLA, AMD, NVDA, PLTR, AMC, BABA, PTON, BBIG, F, SPRT, MSFT, AMZN, FB, PFE, MRNA, BAC, NFLX, SAVA, MARA.

Via Talk Markets

Mid-Day Market Update: Dow Jumps Over 200 Points; Bill.com Shares Spike Higher ↗

August 27, 2021

Midway through trading Friday, the Dow traded up 0.69% to 35,457.78 while the NASDAQ rose 1.03% to 15,099.70. The S&P also rose, gaining 0.79% to 4,505.38. The U.S. has the...

Via Benzinga

Topics Stocks

35 Stocks Moving In Friday's Mid-Day Session ↗

August 27, 2021

Gainers Support.com, Inc. (NASDAQ: SPRT) shares climbed 87% to $36.83 on abnormally high volume amid continued volatility. The stock has recently been mentioned as a potential...

Via Benzinga

Why the Cassava Sciences Bears Are Wrong ↗

August 27, 2021

The stock's been a wild ride for investors all year, and it's dropped about 40% in two days. What's going on, and why am I bullish?

Via The Motley Fool

Why Cassava Sciences Is Plunging Again Today ↗

August 27, 2021

More red flags are emerging for this troubled Alzheimer's biotech company.

Via The Motley Fool

Cassava Stock Dives Again As Lab Distances Itself From 'Data Manipulation' Allegations ↗

August 27, 2021

The lab that tested samples for Cassava's Alzheimer's study distanced itself from the biotech Friday, and SAVA stock plunged again.

Via Investor's Business Daily

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.